Tourmaline Bio, Inc.
TRMLDelisted Oct 28, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827506
Tourmaline Bio, Inc. was delisted on Oct 28, 2025; its insiders filed their last Form 4 on Oct 28, 2025; 134 institutions reported holding it in 13F filings for Q3 2025, worth $1.03B in total; no superinvestor held it.
Q2 2025 vs. Q1 2025
How the institutions holding Tourmaline Bio, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 107 | 109 | +2 |
| Shares | 23.9M | 24.1M | +116.2K (+0.5%) |
| Value | $364.3M | $384.8M | +$20.5M (+5.6%) |
New holders (20)
Institutions that held Tourmaline Bio, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 314,580 | $5.03M | 0.01% |
| Nan Fung Trinity (HK) Ltd | 227,090 | $3.63M | 0.43% |
| Sectoral Asset Management Inc | 116,510 | $1.86M | 1.23% |
| Dimensional Fund Advisors LP | 113,891 | $1.82M | 0.00% |
| Silverarc Capital Management, LLC | 109,257 | $1.75M | 0.36% |
| Susquehanna Portfolio Strategies, LLC | 51,119 | $817.4K | 0.02% |
| Verition Fund Management LLC | 40,030 | $640.1K | 0.00% |
| HRT Financial LP | 26,876 | $429.0K | 0.00% |
| Wesbanco Bank Inc | 26,000 | $415.7K | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 22,056 | $352.7K | 0.01% |
| UBS Asset Management Americas Inc | 16,903 | $270.3K | 0.00% |
| Creative Planning | 12,592 | $201.3K | 0.00% |
| Allostery Investments LP | 9,356 | $149.6K | 1.91% |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 305 | $5.00K | 0.00% |
| SRS Capital Advisors, Inc. | 52 | $832 | 0.00% |
| IFP Advisors, Inc | 0 | $656 | 0.00% |
| Parkside Financial Bank & Trust | 35 | $561 | 0.00% |
| EverSource Wealth Advisors, LLC | 33 | $528 | 0.00% |
| The PNC Financial Services Group, Inc. | 20 | $320 | 0.00% |
| Simplex Trading, LLC | 11 | $0 | 0.00% |
Sold out (18)
Institutions that held Tourmaline Bio, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Citadel Advisors LLC | 570,588 | $8.68M |
| Nan Fung Group Holdings Ltd | 227,090 | $3.45M |
| Federated Hermes, Inc. | 121,245 | $1.84M |
| Jennison Associates LLC | 118,487 | $1.80M |
| Marshall Wace, LLP | 99,166 | $1.51M |
| Wexford Capital LP | 63,610 | $967.5K |
| Two Sigma Investments, LP | 36,643 | $557.3K |
| Jump Financial, LLC | 20,893 | $317.8K |
| UBS Oconnor LLC | 17,860 | $271.7K |
| Caption Management, LLC | 14,312 | $217.7K |
| Two Sigma Advisers, LP | 12,219 | $185.9K |
| Corebridge Financial, Inc. | 11,309 | $172.0K |
| Intech Investment Management LLC | 10,583 | $161.0K |
| HSBC Holdings PLC | 10,357 | $158.4K |
| Jones Financial Companies LLLP | 100 | $1.67K |
| Signaturefd, LLC | 54 | $821 |
| Coldstream Capital Management Inc | 43 | $655 |
| Amundi | 7 | $92 |